Jeffrey Farrow - Chief Financial Officer and Chief Strategy Officer at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer and Chief Strategy Officer
Stock Symbol
TARS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Jeffrey Farrow - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Jeffrey Farrow for Tarsus Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 83.6K $2.56M $30.60 Jun 17, 2024 Direct Common Stock
Stock Option (right to buy) 47.5K $1.8M $10.99 Mar 7, 2024 Direct Common Stock
Common Stock 18.1K $498K $27.47 Jun 18, 2024 Direct

Transactions reported by Jeffrey Farrow for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.